These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15812482)

  • 1. Introducing new vaccines into developing countries: obstacles, opportunities and complexities.
    Clemens J; Jodar L
    Nat Med; 2005 Apr; 11(4 Suppl):S12-5. PubMed ID: 15812482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Policy analysis: an essential research tool for the introduction of vaccines in developing countries.
    Mahoney R
    J Health Popul Nutr; 2004 Sep; 22(3):331-7. PubMed ID: 15609786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.
    Jadhav S; Datla M; Kreeftenberg H; Hendriks J
    Vaccine; 2008 Mar; 26(13):1611-5. PubMed ID: 18294742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs and vaccines around the world.
    Health Aff (Millwood); 2006; 25(2):312. PubMed ID: 16522572
    [No Abstract]   [Full Text] [Related]  

  • 5. A real shot.
    Diamond B
    Nat Med; 2005 Apr; 11(4 Suppl):S3-4. PubMed ID: 15812487
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccines, global health and social equity.
    Levine MM; Robins-Browne R
    Immunol Cell Biol; 2009; 87(4):274-8. PubMed ID: 19308074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines as a global imperative--a business perspective.
    Stéphenne J
    Health Aff (Millwood); 2011 Jun; 30(6):1042-8. PubMed ID: 21653955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines and medicines for the world's poorest. Attempts of global forum for health research should be viewed with optimistic scepticism.
    MacDonald R
    BMJ; 2000 Sep; 321(7264):834. PubMed ID: 11009544
    [No Abstract]   [Full Text] [Related]  

  • 9. Global vaccine project gets a shot in the arm.
    Check E
    Nature; 2005 Jan; 433(7024):345. PubMed ID: 15674258
    [No Abstract]   [Full Text] [Related]  

  • 10. Sociobehavioural research methods for the introduction of vaccines in the Diseases of the Most Impoverished Programme.
    Kaljee LM; Pack R; Pach A; Nyamete A; Stanton BF
    J Health Popul Nutr; 2004 Sep; 22(3):293-303. PubMed ID: 15609782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desirable attributes of vaccines for deployment in low-resource settings.
    Chen D; Zehrung D
    J Pharm Sci; 2013 Jan; 102(1):29-33. PubMed ID: 23136115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A handful of 'antipoverty' vaccines exist for neglected diseases, but the world's poorest billion people need more.
    Hotez P
    Health Aff (Millwood); 2011 Jun; 30(6):1080-7. PubMed ID: 21653960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The need for new vaccines.
    Taylor K; Nguyen A; Stéphenne J
    Vaccine; 2009 Dec; 27 Suppl 6():G3-8. PubMed ID: 20006137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paving the way for the introduction of new vaccines into developing countries.
    Chabalgoity JA
    Expert Rev Vaccines; 2005 Apr; 4(2):147-50. PubMed ID: 15889986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational research to assist policy decisions about introducing new vaccines in developing countries.
    Clemens JD; Jodar L
    J Health Popul Nutr; 2004 Sep; 22(3):223-31. PubMed ID: 15609774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming economic barriers to the optimal use of vaccines.
    Lieu TA; McGuire TG; Hinman AR
    Health Aff (Millwood); 2005; 24(3):666-79. PubMed ID: 15886158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drive to vaccinate children in developing countries faces "acute crisis" because of high costs.
    Moszynski P
    BMJ; 2010 May; 340():c2576. PubMed ID: 20462931
    [No Abstract]   [Full Text] [Related]  

  • 18. The costs of scaling up vaccination in the world's poorest countries.
    Bishai D; McQuestion M; Chaudhry R; Wigton A
    Health Aff (Millwood); 2006; 25(2):348-56. PubMed ID: 16522576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The problems and promise of vaccine markets in developing countries.
    Batson A
    Health Aff (Millwood); 2005; 24(3):690-3. PubMed ID: 15886160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The GO License: only part of the solution.
    Batson A; Milstien JB
    Health Aff (Millwood); 2008; 27(1):140-2. PubMed ID: 18180489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.